Old antibiotics for infections in critically ill patients

Clicks: 253
ID: 274211
2007
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The declining investment of the pharmaceutical industry in the development of new antibiotics and the increasing antimicrobial resistance create a fertile ground for the study and, probably, revival of older antibiotics for use, especially in critically ill patients.
Reference Key
me2007currentold Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Falagas ME;Kopterides P;;
Journal current opinion in critical care
Year 2007
DOI
DOI not found
URL
https://www.ncbi.nlm.nih.gov/pubmed/17762241
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE review humans pubmed abstract nih national institutes of health national library of medicine Bacterial drug resistance anti-bacterial agents / therapeutic use* critical illness* drug utilization gentamicins / therapeutic use chloramphenicol / therapeutic use cross infection / drug therapy* pmid:17762241 doi:10.1097/mcc.0b013e32827851d7 matthew e falagas petros kopterides fosfomycin / therapeutic use fusidic acid / therapeutic use polymyxins / therapeutic use

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.